FOXF:NASDAQFox Factory Holding Corp. Analysis
Data as of 2026-05-30 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Fox Factory (FOXF) is trading at $18.04, comfortably above its 20‑day SMA (≈$17.14) and 50‑day SMA (≈$17.07) but still below the 200‑day SMA (≈$19.86), indicating a short‑term up‑trend within a longer‑term down‑trend. The RSI sits at 56.7, suggesting neutral momentum, while the MACD histogram is positive and the signal line is bearish, delivering a bullish MACD crossover. Volatility is elevated at over 52% for the past 30 days and beta is 1.41, pointing to a stock that moves sharply with the market. Fundamentals show modest revenue growth (≈3.8%) and a gross margin of 29.7%, yet profitability remains weak with a -20% net margin and a trailing EPS of -$7.16, though forward EPS is projected at $1.76. The balance sheet is strained: debt‑to‑equity exceeds 119% and ROE is –37.5%, while cash balances are modest relative to debt. The market has priced in a 23.8% upside to the consensus target of $22, and the forward P/E of 10.3 is attractive for a cyclical consumer play. Recent earnings beat, with Q1 revenue of $368.7 M (+3.9% YoY) and adjusted EBITDA of $35.7 M, reinforced the 2026 outlook and highlighted $50 M of cost‑saving initiatives. Sentiment is at “Extreme Greed” on the fear‑greed index, but the high volatility and debt load temper enthusiasm. Overall, the stock offers a blend of short‑term technical upside and long‑term value concerns, making disciplined positioning essential.
Market Outlook
Short Term
< 1 yearKey Factors
- Q1 earnings beat and strong EBITDA
- Bullish MACD crossover with price above short‑term SMAs
- Technical support at $15.69 offering downside cushion
Medium Term
1–3 yearsKey Factors
- Reaffirmed 2026 sales and EBITDA guidance
- $50 M cost‑saving program improving margin trajectory
- Forward P/E of ~10 suggesting attractive valuation relative to peers
Long Term
> 3 yearsKey Factors
- High debt‑to‑equity ratio and negative ROE signal balance‑sheet risk
- Consumer‑cyclical exposure makes earnings sensitive to economic cycles
- Brand strength and diversified product lines provide a defensive moat
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.